Skip to main content
Log in

Single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 genes in the pathogenesis of polycystic ovary syndrome

  • RESEARCH ARTICLE
  • Published:
Journal of Genetics Aims and scope Submit manuscript

Abstract

Polycystic ovary syndrome (PCOS) is the most common and a complex female endocrine disorder, and is one of the leading cause of female infertility. Here, we aimed to investigate the association of single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 gene in the pathogenesis of PCOS. A hospital-based, observational case–control study was carried on 169 PCOS and 169 control women in the southern region of India. Genotype was carried out by real-time polymerase chain reaction. A chi-square (χ 2) test was performed and the genotypes were verified to comply with the Hardy–Weinberg equilibrium. Odds ratio and 95% confidence interval were calculated to assess the relative risk. Comparison of clinical characteristics of women with PCOS and controls reveal an increase in body mass index (BMI), luteinizing hormone / follicle stimulating hormone (LH/FSH) ratio, glucose levels, insulin, testosterone, hirsutism and antral follicular count in PCOS women. The variant rs1801278 (P=0.002; OR = 2.88; 95% CI = 1.43, 5.80) show an association with PCOS. In the genotypic (P=0.0002) and allelic models (P=0.000), significance persisted even after Bonferroni correction. The genotypes of SNPs strongly influence BMI, LH, LH/FSH ratio, ovarian volume and antral follicular count in PCOS women. The study results were suggestive of a positive association between Gly972Arg of IRS1 and PCOS in the south Indian population, while INS, IRS2, PPAR-G and CAPN10 failed to show any association with PCOS in our studied population. Further studies focussing the role of IRS1 are warranted to delineate its implication towards PCOS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

Similar content being viewed by others

References

  • Adams J. M., Taylor A. E., Crowley W. F. and Hall J. E. 2004 Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. J. Clin. Endocrinol. Metab. 89, 4343–4350.

    Article  CAS  PubMed  Google Scholar 

  • Azziz R., Woods K. S., Reyna R., Key T. J., Knochenhauer E. S. and Yildiz B. O. 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab. 89, 2745–2749.

    Article  CAS  PubMed  Google Scholar 

  • Baba T., Endo T., Sata F., Honnma H., Kitajima Y., Hayashi T. et al. 2007 Polycystic ovary syndrome is associated with genetic polymorphism in the insulin signaling gene IRS-1 but not ENPP1 in a Japanese population. Life Sci. 81, 850–854.

    Article  CAS  PubMed  Google Scholar 

  • Bagheri M., Abdi-Rad I., Hosseini-Jazani N., Zarrin R., Nanbakhsh F. and Mohammadzaie N. 2015 An association study between INSR/NsiI (rs2059806) and INSR/PmlI (rs1799817) SNPs in women with polycystic ovary syndrome from west Azerbaijan province. Iran J. Reprod. Infertil. 16, 109–112.

    PubMed  Google Scholar 

  • Baier L. J., Permana P. A., Yang X., Pratley R. E., Hanson R. L., Shen G. -Q. et al. 2000 A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J. Clin. Invest. 106, R69—R73.

    Article  PubMed Central  Google Scholar 

  • Boomsma C. M., Eijkemans M. J. C., Hughes E. G., Visser G. H. A., Fauser B. C. J. M. and Macklon N. S. 2006 A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum. Reprod. Update 12, 673–683.

    Article  CAS  PubMed  Google Scholar 

  • Carmina E., Orio F., Palomba S., Longo R. A., Cascella T. and Colao A. 2006 Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am. J. Med. 119, 356.

    Article  PubMed  Google Scholar 

  • Chen Z. J., Zhao H., He L., Shi Y., Qin Y., Shi Y. et al. 2011 Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat. Genet. 43, 55–59.

    Article  PubMed  Google Scholar 

  • Dasgupta S. and Reddy B. M. 2013 The role of epistasis in the etiology of polycystic ovary syndrome among Indian women: SNP-SNP and SNP-environment interactions. Ann. Hum. Genet. 77, 288–298.

    Article  CAS  PubMed  Google Scholar 

  • Dasgupta S., Sirisha P., Neelaveni K., Anuradha K., Sudhakar G. and Reddy B. M. 2012 Polymorphisms in the IRS-1 and PPAR-gamma genes and their association with polycystic ovary syndrome among South Indian women. Gene 503, 140–146.

    Article  CAS  PubMed  Google Scholar 

  • De França Neto A. H., Rogatto S., Do Amorim M. M. R., Tamanaha S., Aoki T and Aldrighi J. M. 2010 Oncological repercussions of polycystic ovary syndrome. Gynecol. Endocrinol. 26, 708–711.

    Article  PubMed  Google Scholar 

  • Deeb S. S., Fajas L. and Nemoto M. 1998 A Pro12Ala substitution in PPAR γ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet. 20, 284–287.

    Article  CAS  PubMed  Google Scholar 

  • Dilek S., Ertunc D., Tok E. C., Erdal E. M. and Aktas A. 2005 Association of Gly972Arg variant of insulin receptor substrate-1 with metabolic features in women with polycystic ovary syndrome. Fertil. Steril. 84, 407–412.

    Article  CAS  PubMed  Google Scholar 

  • Doney A. S., Fischer B., Leese G., Morris A. D. and Palmer C. N. 2004 Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a Go-DARTS study. Arterioscler. Thromb. Vasc. Biol. 24, 2403–2407.

    Article  CAS  PubMed  Google Scholar 

  • Ehrmann D. A., Tang X., Yoshiuchi I., Cox N. J. and Bell G. I. 2002 Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 87, 4297–4300.

    Article  CAS  PubMed  Google Scholar 

  • Ferriman D. and Gallwey J. D. 1961 Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab. 21, 1440–1447.

    Article  CAS  PubMed  Google Scholar 

  • Giallauria F., Orio F., Palomba S., Lombardi G., Colao A. and Vigorito C. 2008 Cardiovascular risk in women with polycystic ovary syndrome. J. Cardiovasc. Med. 9, 987–992.

    Article  Google Scholar 

  • Gonzalez Sanchez J., Serrano Rios M., Fernandez Perez C., Laakso M. and Martinez Larrad M. 2002 Effect of the pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. Eur. J. Endocrinol. 147, 495–501.

    Article  CAS  PubMed  Google Scholar 

  • Goodarazi M. O., Erickson S., Port S. C., Jennrich R. I. and Korenman S. G. 2005 Beta-cell function: a key pathological determinant in polycyctic ovary syndrome. J. Clin. Endocrinol. Metab. 90, 310–315.

    Article  Google Scholar 

  • Hara K., Okada T. and Tobe K. 2000 The Pro12Ala polymorphism in PPar gamma2 may confer resistance to type 2 diabetes. Biochem. Biophys. Res. Commun. 271, 212–216.

    Article  CAS  PubMed  Google Scholar 

  • He J., Wang L., Liu J., Liu F. and Li X. 2012 A meta-analysis on the association between PPAR-gamma Pro12Ala polymorphism and polycystic ovary syndrome. J. Assist. Reprod. Genet. 29, 669–677.

    Article  PubMed  PubMed Central  Google Scholar 

  • Horikawa Y., Oda N., Cox N. J., Li X., Orho-Melander M., Hara M. et al. 2000 Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 26, 163–175.

    Article  CAS  PubMed  Google Scholar 

  • Kralovicova J. 2006 Variants in the human insulin gene that affect Pre-mRNA splicing: Is - 23HphI a functional single nucleotide polymorphism at IDDM2? Diabetes 55, 260–264.

    Article  CAS  PubMed  Google Scholar 

  • Le Fur S. 2006 Heterogeneity of class I INS VNTR allele association with insulin secretion in obese children. Physiol. Genomics 25, 480–484.

    Article  PubMed  Google Scholar 

  • Li R., Yu G., Yang D., Li S., Lu S., Wu X. et al. 2014 Prevalence and predictors of metabolic abnormalities in Chinese women with PCOS: A cross-sectional study. BMC Endocr. Disord. 14, 76.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lin M., Huang M. F. and Wu M. H. 2014 Association of Gly972Arg variant of insulin receptor subtrate-1 and Gly1057Asp variant of insulin receptor subtrate-2 with polycystic ovary syndrome in the Chinese population. J. Ovarian Res. 7, 92.

    Article  PubMed  PubMed Central  Google Scholar 

  • Mukherjee S., Shaikh N., Khavale S., Shinde G., Meherji P., Shah N. et al. 2009 Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome. Eur. J. Endocrinol. 160, 855–862.

    Article  CAS  PubMed  Google Scholar 

  • Navaratnarajah R., Pillay O. and Hardiman P. 2008 Polycystic ovary syndrome and endometrial cancer. Semin. Reprod. Med. 26, 62–71.

    Article  PubMed  Google Scholar 

  • Orio F., Cascella T., Giallauria F., Palomba S., De Lorenzo A. and Lucci R. 2006 Polycystic ovary syndrome: an example of obesity-related cardiovascular complication affecting young women. Monaldi. Arch. Chest Dis. 66, 48–53.

    PubMed  Google Scholar 

  • Paquette J., Giannoukakis N., Polychronakos C., Vafiadis P. and Deal C. 1998 The INS 5\(^{\prime }\) variable number of tandem repeats is associated with IGF2 expression in humans. J. Biol. Chem. 273, 14158–14164.

    Article  CAS  PubMed  Google Scholar 

  • Powell B. L., Haddad L., Bennett A., Gharani N., Sovio U., Groves C. J. et al. 2005 Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits. J. Clin. Endocrinol. Metab. 90, 2988–2993.

    Article  CAS  PubMed  Google Scholar 

  • Ruan Y., Ma J. and Xie X. 2012 Association of IRS-1 and IRS-2 genes polymorphisms with polycystic ovary syndrome: A meta-analysis. Endocr. J. 59, 601–609.

    Article  CAS  PubMed  Google Scholar 

  • San-Millan J. L. and Escobar-Morreale H. F. 2010 The role of genetic variation in peroxisome proliferator-activated receptors in the polycystic ovary syndrome (PCOS): an original case-control study followed by systematic review and meta-analysis of existing evidence. Clin. Endocrinol. 72, 383–392.

    Article  CAS  Google Scholar 

  • San Millán J. L., Cortón M., Villuendas G., Sancho J., Peral B and Escobar-Morreale H. F. 2004 Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. J. Clin. Endocrinol. Metab. 89, 2640–2646.

    Article  PubMed  Google Scholar 

  • Shaikh N., Mukherjee A., Shah N., Meherji P. and Mukherjee S. 2013 Peroxisome proliferator activated receptor gamma gene variants influence susceptibility and insulin related traits in Indian women with polycystic ovary syndrome. J. Assist. Reprod. Genet. 30, 913–921.

    Article  PubMed  PubMed Central  Google Scholar 

  • Shen W., Li T., Hu Y., Liu H. and Song M. 2013 Calpain-10 genetic polymorphisms and polycystic ovary syndrome risk: A meta-analysis and meta-regression. Gene 531, 426–434.

    Article  CAS  PubMed  Google Scholar 

  • Shi Y., Zhao H., Cao Y., Yang D., Li Z., Zhang B. et al. 2012 Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat. Genet. 44, 1020–1025.

    Article  CAS  PubMed  Google Scholar 

  • Siegel S., Futterweit W., Davies T. F., Concepcion E. S., Greenberg D. A., Villanueva R. et al. 2002 A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome. Fertil. Steril. 78, 1240–1243.

    Article  PubMed  Google Scholar 

  • Sir-Petermann T., Perez-Bravo F., Angel B., Maliqueo M., Calvillan M. and Palomino A. 2001 G972R polymorphism of IRS-1 in women with polycystic ovary syndrome. Diabetologia 44, 1200–1201.

    Article  CAS  PubMed  Google Scholar 

  • Taylor A. E. 1997 Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 82, 2248–2256.

    CAS  PubMed  Google Scholar 

  • Taylor S. I., Kadowaki T., Kadowaki H., Accili D., Cama A. and McKeon C. 1990 Mutations in insulin-receptor gene in insulin-resistant patients. Diabetes Care 13, 257–279.

    Article  CAS  PubMed  Google Scholar 

  • Tehrani F. M., Daneshpour M., Hashemi S., Zarkesh M. and Azizi F. 2013 Relationship between polymorphism of insulin receptor gene, and adiponectin gene with PCOS. Iran J. Reprod. Med. 11, 185–194.

    CAS  Google Scholar 

  • Urbanek M., Woodroffe A., Ewens K. G., Diamanti-Kandarakis E., Legro R. S. and Strauss J. F. 2005 Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. J. Clin. Endocrinol. Metab. 90, 6623–6629.

    Article  CAS  PubMed  Google Scholar 

  • Vanková M., Vrbíková J., Hill M., Cinek O. and Bendlová B. 2002 Association of insulin gene VNTR polymorphism with polycystic ovary syndrome. Ann. N.Y. Acad. Sci. 967, 558–565.

    Article  PubMed  Google Scholar 

  • Waterworth D. M., Bennett S. T., Gharani N., McCarthy M. I., Hague S., Batty S. et al. 1997 Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet 349, 986–990.

    Article  CAS  PubMed  Google Scholar 

  • Wu X.-K., Sallinen K., Anttila L., Mäkinen M., Luo C., Pöllänen P. et al. 2000 Expression of insulin-receptor substrate-1 and -2 in ovaries from women with insulin resistance and from controls. Fertil. Steril. 74, 564–572.

    Article  CAS  PubMed  Google Scholar 

  • Xu Y., Wei Z., Zhang Z., Xing Q., Hu P., Zhang X. et al. 2009 No association of the insulin gene VNTR polymorphism with polycystic ovary syndrome in a han chinese population. Reprod. Biol. Endocrinol. 7, 141.

    Article  PubMed  PubMed Central  Google Scholar 

  • Yen H. W., Jakimiuk A. J., Munir I. and Magoffin D. A. 2004 Selective alterations in insulin receptor substrates-1,-2 and -4 in theca but not granulosa cells from polycystic ovaries. Mol. Hum. Reprod. 10, 473–479.

    Article  CAS  PubMed  Google Scholar 

  • Zhang H., Bi Y., Hu C., Lu W. and Zhu D. 2012 Association between the Pro12Ala polymorphism of PPAR-gamma gene and the polycystic ovary syndrome: a meta-analysis of case-control studies. Gene 503, 12–17.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

We acknowledge funding from the Department of Biotechnology (DBT), Government of India (project ref. no. BT/PR14090/ GBD/27/275/2010).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to RAVI MADDALY.

Additional information

Corresponding editor: Rajiva Raman

[Thangavelu M., Godla U. R., Paul S. F. D. and Ravi M. 2017 Single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 genes in the pathogenesis of polycystic ovary syndrome. J. Genet. 96, xx–xx]

Electronic supplementary material

Below is the link to the electronic supplementary material.

(PDF 408 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

THANGAVELU, M., GODLA, U.R., PAUL, S.F.D. et al. Single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 genes in the pathogenesis of polycystic ovary syndrome. J Genet 96, 87–96 (2017). https://doi.org/10.1007/s12041-017-0749-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12041-017-0749-z

Keywords

Navigation